(Q50147643)

English

Efficacy of tumor cell vaccine after incorporating monophosphoryl lipid A (MPL) in tumor cell membranes containing tumor-associated ganglioside.

scientific article published in July 1994

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

25 February 2018

http://europepmc.org/abstract/MED/8033972

Efficacy of tumor cell vaccine after incorporating monophosphoryl lipid A (MPL) in tumor cell membranes containing tumor-associated ganglioside. (English)

1 reference

Europe PubMed Central

25 February 2018

http://europepmc.org/abstract/MED/8033972

author name string

M H Ravindranath

1

1 reference

Europe PubMed Central

25 February 2018

http://europepmc.org/abstract/MED/8033972

S M Brazeau

2

1 reference

Europe PubMed Central

25 February 2018

http://europepmc.org/abstract/MED/8033972

D L Morton

3

1 reference

Europe PubMed Central

25 February 2018

http://europepmc.org/abstract/MED/8033972

publication date

1 July 1994

1 reference

Europe PubMed Central

25 February 2018

http://europepmc.org/abstract/MED/8033972

number of pages

6

1 reference

based on heuristic

inferred from page(s)

1 reference

Europe PubMed Central

25 February 2018

http://europepmc.org/abstract/MED/8033972

50

1 reference

Europe PubMed Central

25 February 2018

http://europepmc.org/abstract/MED/8033972

648-653

1 reference

Europe PubMed Central

25 February 2018

http://europepmc.org/abstract/MED/8033972

7

1 reference

Europe PubMed Central

25 February 2018

http://europepmc.org/abstract/MED/8033972

Phase-I study of intravenous modified lipid A.

1 reference

https://api.crossref.org/works/10.1007%2FBF01952865

21 January 2018

The biological modification of tumor cells as a means of inducing their regression: an overview

1 reference

https://pubmed.ncbi.nlm.nih.gov/8033972

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Escape mechanisms of melanoma from immune system by soluble melanoma antigen

1 reference

https://pubmed.ncbi.nlm.nih.gov/8033972

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of pH and polysaccharides on peptide binding to class II major histocompatibility complex molecules

1 reference

https://pubmed.ncbi.nlm.nih.gov/8033972

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Experience with the use of high-dose interleukin-2 in the treatment of 652 cancer patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/8033972

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Role of Gangliosides in Active Immunotherapy with Melanoma Vaccine

1 reference

https://pubmed.ncbi.nlm.nih.gov/8033972

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

BCG and cancer (first of two parts).

1 reference

https://pubmed.ncbi.nlm.nih.gov/8033972

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Human melanoma antigen O-acetylated ganglioside GD3 is recognized by Cancer antennarius lectin

1 reference

https://pubmed.ncbi.nlm.nih.gov/8033972

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Stage II malignant melanoma: presentation of a prognostic model and an assessment of specific active immunotherapy in 1,273 patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/8033972

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prolongation of survival in metastatic melanoma after active specific immunotherapy with a new polyvalent melanoma vaccine.

1 reference

https://pubmed.ncbi.nlm.nih.gov/8033972

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

ELISA for antibodies to lipid A, lipopolysaccharides and other hydrophobic antigens

1 reference

https://pubmed.ncbi.nlm.nih.gov/8033972

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase I trial of a mouse monoclonal antibody against GD3 ganglioside in patients with melanoma: induction of inflammatory responses at tumor sites

1 reference

https://pubmed.ncbi.nlm.nih.gov/8033972

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

MHC interaction and T cell recognition of carbohydrates and glycopeptides

1 reference

https://pubmed.ncbi.nlm.nih.gov/8033972

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Use of tumor-infiltrating lymphocytes and interleukin-2 in the immunotherapy of patients with metastatic melanoma. A preliminary report

1 reference

https://pubmed.ncbi.nlm.nih.gov/8033972

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Syngeneic monoclonal antibody against melanoma antigen with interspecies cross-reactivity recognizes GM3, a prominent ganglioside of B16 melanoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/8033972

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Production of antibodies against phosphocholine, phosphatidylcholine, sphingomyelin, and lipid A by injection of liposomes containing lipid A

1 reference

https://pubmed.ncbi.nlm.nih.gov/8033972

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Enhancement of immunogenicity by incorporation of lipid A into liposomal model membranes and its application to membrane-associated antigens

1 reference

https://pubmed.ncbi.nlm.nih.gov/8033972

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Approaches to augmenting the immunogenicity of the ganglioside GM2 in mice: purified GM2 is superior to whole cells.

1 reference

https://pubmed.ncbi.nlm.nih.gov/8033972

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Increased lysis of melanoma by in vivo-elicited human lymphokine-activated killer cells after addition of antiganglioside antibodies in vitro

1 reference

https://pubmed.ncbi.nlm.nih.gov/8033972

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tumor-specific vaccine containing Mycobacterium bovis and tumor cells: safety and efficacy.

1 reference

https://pubmed.ncbi.nlm.nih.gov/8033972

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Suppression of tumor growth and induction of specific tumor immunity by intradermal inoculation of a mixture of living tumor cells and live Mycobacterium bovis in syngeneic mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/8033972

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A two-step mechanism for the interaction of Re lipopolysaccharide with erythrocyte membranes

1 reference

https://pubmed.ncbi.nlm.nih.gov/8033972

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Membrane lipid composition modulates the binding specificity of a monoclonal antibody against liposomes

1 reference

https://pubmed.ncbi.nlm.nih.gov/8033972

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunogenicity of leukemia L1210 cells after neuraminidase treatment

1 reference

https://pubmed.ncbi.nlm.nih.gov/8033972

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/BF01952865

1 reference

Europe PubMed Central

25 February 2018

http://europepmc.org/abstract/MED/8033972

1 reference

Europe PubMed Central

25 February 2018

http://europepmc.org/abstract/MED/8033972

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q50147643&oldid=1774790875"